Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: MetLife Inc., 3 years.
MetLife Inc.
Director
Vertex Pharmaceuticals Incorporated
Director
agilon health inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2025 | MetLife Inc. | Grant or award | +144 | $78.45 | $11,297 |
| Dec 16, 2024 | MetLife Inc. | Grant or award | +132 | $82.74 | $10,922 |
| Dec 9, 2024 | agilon health inc. | Open-market purchase | +7,500 | $2.20 | $16,500 |
| Nov 25, 2024 | agilon health inc. | Open-market purchase | +12,500 | $2.28 | $28,500 |
| Oct 1, 2024 | MetLife Inc. | Grant or award | +535 | $81.78 | $43,752 |
| Sep 10, 2024 | MetLife Inc. | Grant or award | +141 | $74.63 | $10,523 |
| Jun 18, 2024 | MetLife Inc. | Grant or award | +627 | $69.86 | $43,802 |
| Jun 11, 2024 | MetLife Inc. | Grant or award | +146 | $69.06 | $10,083 |
| May 29, 2024 | agilon health inc. | Grant or award | +32,119 | — | — |
| May 1, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +1,001 | — | — |
| May 1, 2024 | Vertex Pharmaceuticals Incorporated | Sold back to the company | −1,168 | — | — |
| Apr 1, 2024 | MetLife Inc. | Grant or award | +594 | $73.69 | $43,772 |
| Mar 14, 2024 | MetLife Inc. | Grant or award | +129 | $71.90 | $9,275 |
| Jan 2, 2024 | MetLife Inc. | Grant or award | +650 | $67.35 | $43,778 |
| Dec 14, 2023 | MetLife Inc. | Grant or award | +132 | $66.90 | $8,831 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.